Register Login

More on Oral Anticoagulants: Rivaroxaban

Here is a December 19 “FirstWord” post announcing EU clearance of rivaroxaban (Xarelto, Bayer) for stroke prevention and treatment of deep venous thrombosis. Thanks to Steve Duff, Precision BioLogic co-CEO for alerting me to this evidence of the 2011 march to the adoption of new oral anticoagulants.

Comments (0)
Anticoagulant Therapy

No comments here.

Leave a Reply